Interview: Why the Singularity Might Never Come
Linkedin Why the Singularity Might Never Come Jobst Landgrebe is a German scientist and entrepreneur. He began his career as a Fellow at the Max Planck Institute of Psychiatry, then moved on to become a Senior Research Fellow at the University of Göttingen, working in cell biology and biomathematics. In April 2013, he founded Cognotekt, an AI […]
BigData-Insider: AI – Future Decision-Maker and Policeman or Just a Tool?
Linkedin AI – Future Decision-Maker and Policeman or Just a Tool? The World Economic Forum (WEF) is a significant center of power in the global economic and political order. Its founder, visionary and organizer Klaus Schwab, believes that artificial intelligence (AI) will fundamentally change the economy, and automation will render a significant number of current […]
Natural Language Processing (NLP): Where to use it productively
Linkedin Natural Language Processing (NLP): Where to use it productively Language AI series, Part II by Jobst Landgrebe, Cognotekt GmbH The first part of this series, “Meta’s Galactica and other Epic Fails” explained why NLP Large Language Models (LLM) regularly fail and how proponents of AI innovation often overlook the technology’s inherent limits. Let’s now […]
Talk: Artificial Intelligence – Separating Fact From FictionTalk
Linkedin Artificial Intelligence: Separating Fact From Fiction Talk held at the Yale Club of Los Angeles on December 15th, 2022 Notes from the Q&A session Q. Do you think there is an upper limit to the IQ that an AI could score? A. I’m certain it will never achieve a very high IQ because it […]
corrigenda*: AI as a Means of Power – It’s Always the Human
Linkedin AI as a Means of Power – It’s Always the Human A future in which we are ruthlessly controlled by thinking machines: a nightmare. But technology has always served as a means of power. AI can be a power tool when states and companies use it deliberately for this purpose. by Jobst Landgrebe published […]
Natural Language Processing (NLP): Meta’s Galactica and other Epic Fails
Linkedin Natural Language Processing (NLP): Meta’s Galactica and other Epic Fails Language AI series, Part I by Jobst Landgrebe, Cognotekt GmbH Meta Platforms, Inc., the company that owns Facebook, recently shut down Galactica, its AI-based NLP service. Facebook’s Chief AI scientist, Yann LeCun, had previously described Galactica as a Large Language Model [LLM] trained on […]
Interview: Why Machines Will Never Rule the World
Linkedin Irreverend: Why Machines Will Never Rule the World Jamie Franklin (JF): Welcome to this very special episode of “Irreverend: Faith and Current Affairs”. I am extremely excited about this one because I am joined by two eminent thinkers, Professor Barry Smith and Dr Jobst Landgrebe MD who are the authors of this wonderful book […]
The WEF and Artificial Intelligence
Linkedin The WEF and Artificial Intelligence Does AI matter? The head of the Word Economic Forum, Klaus Schwab, and some intellectuals somehow linked to his organisation, such as Yuval Harari or Ray Kurzweil, believe that we are indeed about to witness the coming of the Singularity, a state of affairs in which man-built machines will […]
Tagesspiegel Background: The Drug Crisis Will Worsen
Linkedin Tagesspiegel Background: The Drug Crisis Will Worsen Generics provide at least 95% of the pharmacological basic utility. However, now massive supply bottlenecks are threatening, because manufacturers are shutting down production, writes Jobst Landgrebe, Managing Director of the consulting firm Cognotekt, in the Standpoint. Due to fixed prices and discount contracts, manufacturers could not pass […]
Well intentioned but flawed: The US National Biotechnology and Biomanufacturing Initiative
Linkedin Well intentioned but flawed: The US National Biotechnology and Biomanufacturing Initiative On September 12th, the Biden administration issued an executive order to enhance the development and commercialisation of biotechnology in the United States. This order promises the investment of 2 billion US dollars into subsidizing the biotech industry and to improve the regulatory framework […]
